Page last updated: 2024-09-04

glucagon and oxybutynin

glucagon has been researched along with oxybutynin in 5 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(oxybutynin)
Trials
(oxybutynin)
Recent Studies (post-2010) (oxybutynin)
26,0391,4983,0542,6076191,670

Protein Interaction Comparison

ProteinTaxonomyglucagon (IC50)oxybutynin (IC50)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.5951
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.027
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.002
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0032
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0035
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0027
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.5951
Cytochrome P450 2C19Homo sapiens (human)0.6
D(3) dopamine receptorHomo sapiens (human)0.4288
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.792
Sodium-dependent dopamine transporter Homo sapiens (human)0.0855
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0242

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Branigan, D; Castle, JR; Cummins, M; Newswanger, B; Prestrelski, S; Shi, L; Strange, P; Youssef, JE1
GhavamiNejad, A; Giacca, A; Lam, L; Li, J; Lu, B; Wu, XY; Zhou, L1
Buse, JB; Chen, G; Gu, Z; Kahkoska, AR; Li, H; Miedema, JR; Wang, J; Wang, Z; Wen, D; Wu, V; Yu, J; Zeng, Y1
GhavamiNejad, A; Giacca, A; Liu, JF; Lu, B; Mirzaie, S; Pereira, S; Samarikhalaj, M; Wu, XY; Zhou, L1
Fu, R; Gu, Z; Han, X; Li, S; Wang, Z; Wen, D; Wu, Y1

Trials

1 trial(s) available for glucagon and oxybutynin

ArticleYear
Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects.
    Journal of diabetes science and technology, 2016, Volume: 10, Issue:5

    Topics: Adult; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Middle Aged; Transdermal Patch; Young Adult

2016

Other Studies

4 other study(ies) available for glucagon and oxybutynin

ArticleYear
Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    Advanced materials (Deerfield Beach, Fla.), 2019, Volume: 31, Issue:30

    Topics: Animals; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Liberation; Gels; Glucagon; Humans; Hyaluronic Acid; Hypoglycemia; Hypoglycemic Agents; Insulin; Methacrylates; Needles; Photochemical Processes; Polymerization; Rats; Transdermal Patch

2019
Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 11-24, Volume: 117, Issue:47

    Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Overdose; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Polymerization; Solubility; Streptozocin; Transdermal Patch

2020
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
    Drug delivery and translational research, 2022, Volume: 12, Issue:4

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Systems; Glucagon; Humans; Hypoglycemia; Insulin; Needles; Polymers; Rats; Receptors, Somatostatin; Technology; Transdermal Patch

2022
Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:28

    Topics: Animals; Biocompatible Materials; Diabetes Mellitus; Glucagon; Glucose; Hypoglycemia; Insulin; Mice; Transdermal Patch

2022